Enter your login e-mail to the account
Search
Search parameters
Search results
- Multiple sclerosis and motherhood The article deals with the relationship of multiple
MUDr. Viera Hančinová
(1/2013, Interdisciplinary consilium ) - Possibilities for early detection of patients with the diagnosis of MS in general practitioner
prof. MUDr. Egon Kurča, PhD., MUDr. Natália Jankovičová,
(3/2016, Interdisciplinary consilium ) - Sclerosis multiplex – informácie pre prax
doc. MUDr. Eleonóra Klímová, CSc.
(5/2006, Consilium )
- Multiple sclerosis – psychoneuroimmunological disease of the central nervous system
doc. MUDr. Eva Havrdová, CSc., MUDr. Eva Krasulová, Mgr. Jana Blahová Dušánková
(3/2009, Review articles )
- New drugs era in treating multiple sclerosis
MUDr. Marta Vachová
(5/2009, Review articles ) - Profile of a patient with secondary progressive MS – how to identify patients that should be sent to a tertiary Center
MUDr. Hana Mojžišová, MUDr. Martin Elišák, Ph.D.
(5/2021, Review articles ) - Glatiramer acetate: long-term immunomodulatory therapy in multiple sclerosis – safety, efficacy, adherence and persistence assesment
MUDr. Olga Zapletalová
(2/2016, Review articles ) - Anti CD20 multiple sclerosis therapy
Doc. MUDr. Pavel Štourač, Ph.D.
(1/2018, Pharmacotherapy ) - Imunomodulační terapie u sclerosis multiplex
MUDr. Pavel Štourač, Ph.D.
(5/2002, Main topic ) - Woman and multiple sclerosis
doc. MUDr. Jarmila Szilasiová, PhD.
(6/2014, Main topic ) - Recent advances in treatment of multiple sclerosis with interferon beta in Czech Republic?
MUDr. Michal Dufek
(1/2011, Review articles ) - Ocrelizumab – pharmacoloical profile
doc. MUDr. Radomír Taláb, CSc., MUDr. Marika Talábová
(5/2018, Pharmacotherapy ) - Pharmacology, efficacy and safety of natalizumab in an extended interval dosing
doc. MUDr. Ema Kantorová, PhD.
(4/2023, Informations ) - Importance of early diagnosis and treatment in the life perspective of patients with multiple sclerosis
doc. MUDr. Jan Mareš, Ph.D.
(5/2012, Review articles ) - NEDA-4 concept as a treatment outcome in multiple sclerosis patients
MUDr. Pavel Hradílek, Ph.D.
(3/2016, Review articles ) - Adherence to treatment in multiple sclerosis
MUDr. Pavel Hradílek, Ph.D.
(3/2012, Review articles ) - Súčasné možnosti dlhodobej liečby roztrúsenej sklerózy: výhody a nevýhody perorálnej liečby roztrúsenej sklerózy
MUDr. Zuzana Matejčíková, Ph.D.
(3/2018, Review articles ) - Alemtuzumab in multiple sclerosis treatment
MUDr. Eva Meluzínová
(4/2015, Pharmacotherapy ) - Ocrelizumab – long-term efficacy and safety in real-world clinical practice in patients with relapsingremitting multiple sclerosis
MUDr. Martin Elišák, Ph.D.
(3/2022, Review articles ) - PEGylated interferon beta-1a: a novel interferon in treating multiple sclerosis
MUDr. Pavel Hradílek, Ph.D.
(4/2017, Review articles ) - Escalation vs. induction therapy in multiple sclerosis
MUDr. Marek Peterka
(4/2017, Review articles ) - Treatment with the monoclonal antibody alemtuzumab: effect on the manifestation of thyroid disorders
Prof. MUDr. Petr Vlček, CSc., RNDr. Dana Nováková
(4/2017, From the boundary of neurology ) - Léčba relaps-remitentní roztroušené sklerózy mozkomíšní
doc. MUDr. Eva Havrdová, CSc., MUDr. Eva Krasulová
(4/2008, Main topic ) - New ways of administering injection drugs in relapsing multiple sclerosis
MUDr. Jiří Piťha
(5/2015, Review articles ) - Clinically isolated syndrome and treatment with glatiramer acetate
MUDr. Radek Ampapa, MUDr. Vladislav Cunder, MUDr. Martin Svárovský
(2/2015, Case reports ) - Correlation between magnetic resonance imaging and clinical disability in multiple sclerosis
prof. MUDr. Zdeněk Seidl, CSc., doc. MUDr. Manuela Vaněčková, Ph.D.
(5/2014, Review articles ) - Does the development of new drugs for multiple sclerosis change the prognosis of the patient?
prof. MUDr. Eva Havrdová, CSc.
(3/2011, Review articles ) - Ocrelizumab and novel therapeutic goals in multiple sclerosis
MUDr. Radek Ampapa
(2/2020, Review articles )